Fermion-Header

Fermion-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

Gesynta Pharma

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Boulder Peptide Symposium

Participation Not Confirmed

Update your Virtual Booth

Gesynta raises SEK 190M in Round Led by Hadean Ventures to Accelerate Development of ...

Lead Product(s): GS-248

Therapeutic Area: Dermatology Product Name: GS-248

Highest Development Status: Phase I Product Type: Small molecule

Partner/Sponsor/Collaborator: Hadean Ventures

Deal Size: $21.1 million Upfront Cash: Undisclosed

Deal Type: Financing July 07, 2020

Details:

The investment enables Gesynta to fund continued development of lead candidate GS-248 in systemic sclerosis patients.